Gender Differences in Human Immunodeficiency Virus Type 1-Specific CD8 Responses in the Reproductive Tract and Colon following Nasal Peptide Priming and Modified Vaccinia Virus Ankara Boosting
Open Access
- 1 December 2004
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 78 (23) , 13163-13172
- https://doi.org/10.1128/jvi.78.23.13163-13172.2004
Abstract
Induction of mucosal anti-human immunodeficiency virus type 1 (HIV-1) T-cell responses in males and females will be important for the development of a successful HIV-1 vaccine. An HIV-1 envelope peptide, DNA plasmid, and recombinant modified vaccinia virus Ankara (rMVA) expressing the H-2Dd-restricted cytotoxic T lymphocyte P18 epitope were used as immunogens to test for their ability to prime and boost anti-HIV-1 T-cell responses at mucosal and systemic sites in BALB/c mice. We found of all prime-boost combinations tested, an HIV-1 Env peptide subunit mucosal prime followed by systemic (intradermal) boosting with rMVA yielded the maximal induction of gamma interferon (IFN-γ) spot-forming cells in the female genital tract and colon. However, this mucosal prime-systemic rMVA boost regimen was minimally immunogenic for the induction of genital, colon, or lung anti-HIV-1 T-cell responses in male mice. We determined that a mucosal Env subunit immunization could optimally prime an rMVA boost in female but not male mice, as determined by the magnitude of antigen-specific IFN-γ responses in the reproductive tracts, colon, and lung. Defective mucosal priming in male mice could not be overcome by multiple mucosal immunizations. However, rMVA priming followed by an rMVA boost was the optimal prime-boost strategy for male mice as determined by the magnitude of antigen-specific IFN-γ responses in the reproductive tract and lung. Thus, prime-boost immunization strategies able to induce mucosal antigen-specific IFN-γ responses were identified for male and female mice. Understanding the cellular and molecular basis of gender-determined immune responses will be important for optimizing induction of anti-HIV-1 mucosal immune responses in both males and females.Keywords
This publication has 86 references indexed in Scilit:
- Immunoglobulins in Human Seminal PlasmaAndrologia, 2009
- A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaquesVaccine, 2004
- Tissue distribution of the Ankara strain of vaccinia virus (MVA) after mucosal or systemic administrationArchiv für die gesamte Virusforschung, 2003
- Cytokines as Adjuvants for the Induction of Anti-Human Immunodeficiency Virus Peptide Immunoglobulin G (IgG) and IgA Antibodies in Serum and Mucosal Secretions after Nasal ImmunizationJournal of Virology, 2002
- IL-12-Dependent Enhancement of CTL Response to Weak Class I-Restricted Peptide Immunogens Requires Coimmunization with T Helper Cell ImmunogensClinical Immunology, 2000
- Urethral Glands of the Male Mouse Contain Secretory Component and Immunoglobulin a Plasma Cells and are Targets of Testosterone1Biology of Reproduction, 1992
- Induction of Mucosal and Systemic Immunity to a Recombinant Simian Immunodeficiency Viral ProteinScience, 1992
- Identification of a major human immunodeficiency virus‐1 reverse transcriptase epitope recognized by mouse CD4+ T lymphocytesEuropean Journal of Immunology, 1991
- T cell multideterminant regions in the human immunodeficiency virus envelope: toward overcoming the problem of major histocompatibility complex restrictionInternational Immunology, 1989
- STUDIES OF THE REGULATORY EFFECTS OF THE SEX HORMONES ON ANTIBODY FORMATION AND STEM CELL DIFFERENTIATIONThe Journal of Experimental Medicine, 1972